跳至主要内容
临床试验/NCT00262574
NCT00262574Unknown4 期

Phase 4 Study of Patients Receiving BNP or NTG (IV) During Angioplasty, Re-examined 24 Hours Later Using the Flow-mediated Brachial Artery Dilation Study, and Blood Assays for Pro BNP and ET1

The Baruch Padeh Medical Center, Poriya2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2005年7月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
500
试验地点
2
主要终点
FMD

研究概览

简要总结

Patients receiving BNP or nitroglycerin (IV) during the angioplasty procedure. 24 h after the procedure, vascular reactivity will be re-examined using the brachial artery flow-mediated dilatation study. Blood assays for ET-1, pro-BNP, and various inflammatory markers will be checked before and 24 h after the procedure. It is our hypothesis that endothelial function will be better in the BNP treated patients compared to the NTG treated patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • coronary artery disease -

排除标准

  • CHF and/or reduced LV function, or renal failure with Creatinine >2mg%

结局指标

主要结局

FMD

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验

Effect of BNP (Brain Natriuretic Peptides) on... | 临床试验